Stocks · News reference

Galmed Pharmaceuticals shares are trading higher after the company's subsidiary Colospan announced the completion of a feasibility study supporting the development of a novel intraoperative colon tissue quality assessment platform.

Aug 19, 2026, 2:07 PMBenzinga Newsdesk

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 19, 2026, 2:07 PM
Checked: Aug 19, 2026, 2:07 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaSep 9, 2026, 6:14 PMBenzinga Newsdesk
Galmed Pharmaceuticals shares are trading higher after the company announced a corporate rebranding to Eocene and a change in the trading symbol of the Company on the Nasdaq to "EOCN."
GLMD
BenzingaSep 9, 2026, 11:32 AMBenzinga Newsdesk
Galmed Pharmaceuticals Announces Rebrand To Eocene And Nasdaq Ticker Change From GLMD To EOCN Effective September 10; Announces Termination Of Yorkville Standby Equity Purchase Agreement Effective September 8
GLMD
BenzingaAug 19, 2026, 12:55 PMBenzinga Newsdesk
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
GLMD